Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 or older, of any gender
- People who have been diagnosed with Parkinson's disease following a specific 2015 medical guideline, meaning they have slowness of movement plus at least one of either muscle stiffness or a tremor at rest, with no other known cause for their symptoms
- People whose Parkinson's disease was diagnosed less than 6 years ago
- People who do not currently have clinically meaningful impulse control or related behaviours (such as compulsive gambling, eating, or shopping), as measured by a specific assessment tool (confirm with trial site)
- People who have been taking a dopamine agonist medication for at least 2 months and have no known or planned reason to stop taking it over the next 3 years
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have an atypical or secondary form of parkinsonism, such as supranuclear palsy, multisystem atrophy, or parkinsonism caused by medication
- People who have a cognitive or psychiatric condition that, in the treating doctor's judgement, would prevent them from participating in the trial
- People who are not willing to take part in the trial or to sign a consent form
- People who are pregnant or breastfeeding, or people of childbearing potential whose pregnancy test has come back positive
- People who have taken part in a trial of an investigational drug within 30 days before screening, or within 5 half-lives of that investigational product, whichever period is longer (confirm with trial site)
- People who are not affiliated with or covered by the French social security system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Louise-Laure Mariani, Assistance Publique - Hôpitaux de Paris
Phone: 01 42 16 27 48
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Rate of patients with at least one clinically significant ICDRBs, i.e mild or above (any ASBPD score at 2 or above in any of the subcategories 3 to 5 and 7 to 10 of part IV) over the 3 year-follow up.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.